Defining the Next Generation of Drug-Coated Balloon Technology

[1]  Juan F Granada,et al.  Drug-coated balloons for the prevention of vascular restenosis. , 2010, Circulation.

[2]  G. Tepe,et al.  Advances on drug-coated balloons. , 2010, The Journal of cardiovascular surgery.

[3]  M. Böhm,et al.  Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model , 2009, Clinical Research in Cardiology.

[4]  B. Hamm,et al.  Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial , 2008, Circulation.

[5]  C. Claussen,et al.  Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. , 2008, The New England journal of medicine.

[6]  M. Böhm,et al.  Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2006, Clinical research in cardiology : official journal of the German Cardiac Society.

[7]  M. Böhm,et al.  Reduction of Stenosis Due to Intimal Hyperplasia After Stent Supported Angioplasty of Peripheral Arteries by Local Administration of Paclitaxel in Swine , 2007, Investigative radiology.

[8]  D. Desilvey.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2007, The American journal of geriatric cardiology.

[9]  M. Böhm,et al.  Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis , 2004, Circulation.

[10]  M. Böhm,et al.  Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. , 2003, Journal of the American College of Cardiology.

[11]  M. Böhm,et al.  Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. , 2003, European heart journal.